Changes of Metabolic Biomarker Levels upon One-Year Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis: Associations with Vascular Pathophysiology.

Monika CzókolyováAnita PusztaiEdit VéghÁgnes HorváthAnita SzentpéteriAttila HamarSzilvia SzamosiKatalin HodosiAndrea DomjánSándor SzántóGyörgy KerekesIldikó SeresMariann HarangiGyörgy ParaghÉva SzekaneczZoltán SzekaneczGabriella Szűcs

Published in: Biomolecules (2021)

Assessment of various metabolic parameters together with disease activity, CRP, and ultrasound-based techniques may exert additional value in determining CV burden and in monitoring the effects of biologics on preclinical vascular pathophysiology.

Keyphrases

disease activity
ankylosing spondylitis
rheumatoid arthritis
rheumatoid arthritis patients
systemic lupus erythematosus
juvenile idiopathic arthritis
interstitial lung disease
magnetic resonance imaging
cell therapy
stem cells
computed tomography
mesenchymal stem cells
risk factors